Clene to Present at Upcoming May Conferences
May 14, 2024 08:00 ET
|
Clene Inc.
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage...
SQSP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Squarespace to Permira
May 13, 2024 09:20 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the sale of Squarespace to Permira for $44.00 per share in cash.
Zevra Therapeutics to Participate at Upcoming Investor Events
May 09, 2024 07:30 ET
|
Zevra Therapeutics
CELEBRATION, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane,...
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2034
May 08, 2024 16:10 ET
|
Phillips Edison & Company, Inc.
CINCINNATI, May 08, 2024 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of grocery-anchored...
Inaugural Mizuho DrivHER Summit at the Mizuho Americas Open to Inspire the New Generation of Women Leaders
May 02, 2024 08:00 ET
|
Mizuho Americas
The inaugural Mizuho DrivHER Summit. The event, developed in conjunction with Girls Inc., will take place on May 15, 2024, at the Mizuho Americas Open.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 01, 2024 15:20 ET
|
Schall Law
The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 24, 2024 16:01 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization...
[Press Release] iliad SA successfully completes a €500 million bond issue
April 22, 2024 14:13 ET
|
Iliad
PRESS RELEASE Paris, April 22, 2024 iliad SA successfully completes a €500 million bond issuefinancial release Today, iliad SA successfully placed a €500 million bond issue. The bonds...
[Communiqué de presse] iliad SA émet avec succès un emprunt obligataire de 500 millions d’euros
April 22, 2024 14:13 ET
|
Iliad
COMMUNIQUE DE PRESSE Paris, le 22 avril 2024 iliad SA émet avec succès un emprunt obligataire de 500 millions d’euros communication financière iliad SA a placé ce jour...
RadNet Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction
April 18, 2024 16:05 ET
|
RadNet, Inc.
LOS ANGELES, April 18, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today...